199 related articles for article (PubMed ID: 28437283)
1. Dilator Use After Vaginal Brachytherapy for Endometrial Cancer: A Randomized Feasibility and Adherence Study.
Hanlon A; Small W; Strauss J; Lin LL; Hanisch L; Huang L; Bai J; Wells J; Bruner DW
Cancer Nurs; 2018; 41(3):200-209. PubMed ID: 28437283
[TBL] [Abstract][Full Text] [Related]
2. Can an educational intervention improve compliance with vaginal dilator use in patients treated with radiation for a gynecological malignancy?
Brand AH; Do V; Stenlake A
Int J Gynecol Cancer; 2012 Jun; 22(5):897-904. PubMed ID: 22552831
[TBL] [Abstract][Full Text] [Related]
3. From "sex toy" to intrusive imposition: a qualitative examination of women's experiences with vaginal dilator use following treatment for gynecological cancer.
Cullen K; Fergus K; Dasgupta T; Fitch M; Doyle C; Adams L
J Sex Med; 2012 Apr; 9(4):1162-73. PubMed ID: 22304701
[TBL] [Abstract][Full Text] [Related]
4. Qualitative accounts of patients' determinants of vaginal dilator use after pelvic radiotherapy.
Bakker RM; Vermeer WM; Creutzberg CL; Mens JW; Nout RA; Ter Kuile MM
J Sex Med; 2015 Mar; 12(3):764-73. PubMed ID: 25424559
[TBL] [Abstract][Full Text] [Related]
5. Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer.
Bahng AY; Dagan A; Bruner DW; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):667-73. PubMed ID: 21300451
[TBL] [Abstract][Full Text] [Related]
6. Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy.
Stahl JM; Qian JM; Tien CJ; Carlson DJ; Chen Z; Ratner ES; Park HS; Damast S
Support Care Cancer; 2019 Apr; 27(4):1425-1433. PubMed ID: 30187220
[TBL] [Abstract][Full Text] [Related]
7. Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma.
Park HS; Ratner ES; Lucarelli L; Polizzi S; Higgins SA; Damast S
Brachytherapy; 2015; 14(4):464-70. PubMed ID: 25887343
[TBL] [Abstract][Full Text] [Related]
8. The impact of vaginal dilator use on vaginal stenosis and sexual quality of life in women treated with adjuvant radiotherapy for endometrial cancer.
Akbaba S; Oelmann-Avendano JT; Krug D; Arians N; Bostel T; Hoerner-Rieber J; Nicolay NH; Debus J; Lindel K; Foerster R
Strahlenther Onkol; 2019 Oct; 195(10):902-912. PubMed ID: 30997541
[TBL] [Abstract][Full Text] [Related]
9. Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer.
Friedman LC; Abdallah R; Schluchter M; Panneerselvam A; Kunos CA
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):751-7. PubMed ID: 20619551
[TBL] [Abstract][Full Text] [Related]
10. A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer.
Bakker RM; Mens JW; de Groot HE; Tuijnman-Raasveld CC; Braat C; Hompus WC; Poelman JG; Laman MS; Velema LA; de Kroon CD; van Doorn HC; Creutzberg CL; Ter Kuile MM
Support Care Cancer; 2017 Mar; 25(3):729-737. PubMed ID: 27787681
[TBL] [Abstract][Full Text] [Related]
11. Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
Martins J; Vaz AF; Grion RC; Costa-Paiva L; Baccaro LF
BMC Cancer; 2021 Jun; 21(1):682. PubMed ID: 34112100
[TBL] [Abstract][Full Text] [Related]
12. Vaginal dilator therapy for women receiving pelvic radiotherapy.
Miles T; Johnson N
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD007291. PubMed ID: 25198150
[TBL] [Abstract][Full Text] [Related]
13. Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage I-II endometrial cancer: A monoinstitutional experience.
Perrucci E; Lancellotta V; Bini V; Zucchetti C; Mariucci C; Montesi G; Saccia S; Palumbo I; Aristei C
Brachytherapy; 2016; 15(2):177-84. PubMed ID: 26727332
[TBL] [Abstract][Full Text] [Related]
14. Sexual rehabilitation after pelvic radiotherapy and vaginal dilator use: consensus using the Delphi method.
Bakker RM; ter Kuile MM; Vermeer WM; Nout RA; Mens JW; van Doorn LC; de Kroon CD; Hompus WC; Braat C; Creutzberg CL
Int J Gynecol Cancer; 2014 Oct; 24(8):1499-506. PubMed ID: 25248115
[TBL] [Abstract][Full Text] [Related]
15. Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients?
Nieto K; Martin B; Pham N; Palmere L; Silva SR; Winder A; Liotta M; Potkul RK; Small W; Harkenrider MM
Brachytherapy; 2018; 17(6):929-934. PubMed ID: 30227976
[TBL] [Abstract][Full Text] [Related]
16. Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies?
Dohopolski MJ; Horne ZD; Gebhardt BJ; Glaser SM; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Berger JL; Sukumvanich P; Beriwal S
Brachytherapy; 2018; 17(3):564-570. PubMed ID: 29426745
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for long-term quality of life after adjuvant radiotherapy in women with endometrial cancer.
Foerster R; Schnetzke L; Bruckner T; Arians N; Rief H; Debus J; Lindel K
Strahlenther Onkol; 2016 Dec; 192(12):895-904. PubMed ID: 27605238
[TBL] [Abstract][Full Text] [Related]
18. Three or four fractions per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. The long-term results on vaginal relapses and toxicity.
Valduvieco I; Rovirosa Á; Herreros A; Romera I; Ríos I; Ascaso C; Sánchez-Reyes A; Arenas M; Pahisa J; Biete A
Clin Transl Oncol; 2013 Aug; 15(8):602-7. PubMed ID: 23263910
[TBL] [Abstract][Full Text] [Related]
19. Three or four fractions of 4-5 Gy per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma.
Rovirosa A; Ascaso C; Sánchez-Reyes A; Herreros A; Abellana R; Pahisa J; Lejarcegui JA; Biete A
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):418-23. PubMed ID: 20800388
[TBL] [Abstract][Full Text] [Related]
20. Change in vaginal length and sexual function in women who undergo surgery ± radiation therapy for endometrial cancer.
Quinn BA; Deng X; Sullivan SA; Carter J; Bandyopadhyay D; Fields EC
Brachytherapy; 2023; 22(3):334-342. PubMed ID: 36849277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
